HOXD13 — Homeobox D13
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HOXD13 — Homeobox D13</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HOXD13</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Homeobox D13</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>2q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3239" target="_blank">3239</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128714" target="_blank">ENSG00000128714</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/142989" target="_blank">142989</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P09030" target="_blank">P09030</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>312 amino acids</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Homeobox, HOXD family</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cortex, Hippocampus, Cerebellum, Spinal cord, Limb buds</td>
</tr>
<tr>
<td class="label">Key Diseases</td>
<td>Synpolydactyly, Huntington's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
HOXD13 — Homeobox D13
Overview
HOXD13 (Homeobox D13) is a human gene located on chromosome 2q31.1 that encodes a transcription factor critical for embryonic development, particularly limb and digit formation. The gene is catalogued as NCBI Gene ID [3239](https://www.ncbi.nlm.nih.gov/gene/3239), OMIM [142989](https://www.omim.org/entry/142989), and encodes a 312-amino acid protein with a conserved homeodomain DNA-binding motif [1](https://www.ncbi.nlm.nih.gov/gene/3239).
HOXD13 belongs to the HOX gene family—a highly conserved group of transcription factors that specify positional identity along the anterior-posterior axis of the developing embryo. The HOXD cluster (HOXD1-HOXD13) is located on chromosome 2 and is expressed in a collinear manner, with genes at the 3' end of the cluster (like HOXD13) specifying posterior structures [3](https://doi.org/10.1038/s41576-021-00317-5). While primarily studied for its role in limb development, HOXD13 is also expressed in the developing nervous system and has been implicated in [neurodegenerative diseases](/diseases/neurodegeneration), including [Parkinson's disease](/diseases/parkinsons-disease) and [Huntington's disease](/diseases/huntingtons) [6](https://doi.org/10.1016/j.nbd.2023.105896).
This page reviews HOXD13's normal biological function, developmental roles, expression in the nervous system, disease associations, and therapeutic implications.
Normal Biological Function
The HOX Gene Family and the HOX Code
The HOX genes are a conserved family of transcription factors that provide positional information during embryonic development. In vertebrates, there are 39 HOX genes organized into four clusters (HOXA, HOXB, HOXC, HOXD) located on different chromosomes. Each cluster contains 9-13 genes arranged in paralog groups, and the genes within a cluster are expressed in a collinear manner—genes at the 3' end are expressed earlier and more anteriorly, while genes at the 5' end are expressed later and specify more posterior structures [3](https://doi.org/10.1038/s41576-021-00317-5).
The "HOX code" refers to the combination of HOX proteins expressed in a given cell, which determines its developmental fate. For example, motor neurons in different segments of the spinal cord express different combinations of HOX proteins, conferring them with specific axonal projection patterns [12](https://doi.org/10.1016/j.conb.2021.02.003). HOXD13, as the most posterior gene in the HOXD cluster, plays key roles in specifying the most distal (fingertip) structures.
Homeodomain Structure and DNA Binding
HOXD13 encodes a transcription factor with a conserved homeodomain—a 60-amino acid DNA-binding helix-turn-helix motif [11](https://doi.org/10.1146/annurev-biochem-040320-103436). The homeodomain consists of:
N-terminal arm: Contacts the minor groove of DNA
Helix 3 (recognition helix): Binds the major groove, recognizing specific DNA sequences
C-terminal tail: Modulates interaction with co-factorsThe consensus binding site for HOX proteins is the TAAT motif (with variations conferring specificity). HOXD13 typically binds as a monomer to these sites, though it can also form heterodimers with other homeodomain proteins like PBX and MEIS for more specific DNA recognition [9](https://doi.org/10.1016/j.ceb.2021.03.007).
Role in Limb Development
HOXD13 is essential for proper limb formation, particularly digit development. The gene is expressed in the distal limb bud during embryonic development, where it:
Specifies digit identity: HOXD13 contributes to specifying the identity of digits (fingers and toes)
Controls digit number: Regulates the number of digits formed
Promotes digit elongation: Controls the growth and elongation of digit bones
Patterns digit joints: Regulates joint formation within digitsThe SHFM1 (Split Hand/Foot Malformation Type 1) phenotype associated with HOXD13 mutations illustrates the gene's critical role in limb development [2](https://doi.org/10.1016/j.ydbio.2020.02.016).
Polyalanine Expansions and Synpolydactyly
The most well-characterized HOXD13 mutations are polyalanine expansions in the N-terminal region of the protein. Normal HOXD13 contains a 9-alanine stretch; pathogenic expansions to 14-22 alanines cause synpolydactyly—a condition featuring extra digits (polydactyly) and fusion of digits (syndactyly) [4](https://doi.org/10.1093/hmg/ddac127). The mechanism involves:
- Reduced transcriptional activity: Expanded polyalanine tracts may impair HOXD13's ability to activate target genes
- Altered protein-protein interactions: The expansion may disrupt interactions with co-factors
- Potential toxic gain-of-function: In some contexts, expanded polyalanine tracts may form toxic aggregates [10](https://doi.org/10.1093/hmg/gyaa012)
Expression in the Nervous System
Brain Region Expression
HOXD13 is expressed in multiple regions of the developing and adult nervous system [5](https://doi.org/10.1038/s41583-021-00435-3):
- Cerebral Cortex: Expression in pyramidal neurons, particularly in layers 5-6
- Hippocampus: Present in CA1-CA3 pyramidal neurons and dentate gyrus
- Cerebellum: Expression in Purkinje cells and deep cerebellar nuclei
- Spinal cord: Expression in motor neurons and interneurons
- Thalamus: Present in specific thalamic nuclei
- Basal ganglia: Expression in striatal neurons
The expression pattern suggests HOXD13 may have functions beyond limb development, potentially in neuronal differentiation, migration, and connectivity.
Role in Neural Development
During development, HOX genes including HOXD13 pattern the neural tube along the anterior-posterior axis [13](https://doi.org.org/10.1016/j.devcel.2020.02.015):
Regional specification: HOX proteins confer regional identity to neural progenitors
Neuron subtype specification: Different HOX combinations specify different neuronal subtypes
Axon guidance: HOX expression in neurons influences their axonal projection patterns
Synapse formation: HOX genes may regulate the formation of specific synaptic connectionsIn the spinal cord, HOX genes pattern motor neuron pools, with HOXD13 particularly expressed in motor neurons innervating distal limb muscles [14](https://doi.org/10.1016/j.conb.2021.02.003). This "HOX code" determines the specific muscle targets of different motor neuron populations.
Disease Associations
Parkinson's Disease
Recent research has revealed HOXD13 dysregulation in [Parkinson's disease](/diseases/parkinsons-disease) [6](https://doi.org/10.1016/j.nbd.2023.105896):
- Reduced expression: HOXD13 mRNA and protein levels are decreased in the [substantia nigra pars compacta](/cell-types/dopaminergic-neurons) of Parkinson's disease patients
- Cellular specificity: The reduction is specific to dopaminergic neurons, the cells that degenerate in Parkinson's disease
- Potential mechanism: Oxidative stress and mitochondrial dysfunction may contribute to HOXD13 downregulation
The significance of HOXD13 reduction in Parkinson's disease is under investigation. Potential implications include:
Transcriptional dysregulation: HOXD13 may regulate genes important for dopaminergic neuron survival
Developional memory: Neurons may require HOXD13 for maintenance of differentiated state
Regenerative potential: Reduced HOXD13 may impair the brain's ability to respond to injuryHuntington's Disease
HOXD13 expression is also altered in [Huntington's disease](/diseases/huntingtons) [7](https://doi.org/10.1093/brain/awac370):
- Dysregulated expression: HOXD13 mRNA levels are changed in the cortex of Huntington's disease patients
- Correlation with disease progression: Expression changes may correlate with disease severity
- Potential role in medium spiny neuron dysfunction: Altered HOXD13 may contribute to the distinctive degeneration of medium spiny neurons in the striatum
The transcriptional dysregulation of HOXD13 in Huntington's disease adds to the broader pattern of HOX gene dysregulation observed in this condition [19](https://doi.org/10.1016/j.pneurobio.2023.102498).
Alzheimer's Disease
While less studied, HOXD13 may also be relevant to [Alzheimer's disease](/diseases/alzheimers-disease):
- Expression changes: Some studies report altered HOXD13 expression in Alzheimer's disease brains
- Potential targets: HOXD13 may regulate genes involved in amyloid processing or tau phosphorylation
- Therapeutic implications: Restoring HOXD13 expression could potentially provide neuroprotective effects
Developmental Syndromes
HOXD13 mutations cause several developmental syndromes:
Synpolydactyly (SPD): Polyalanine expansions cause the characteristic digital malformations
Brachydactyly: Certain HOXD13 variants cause shortened digits
SHFM1 (Split Hand/Foot Malformation Type 1): Chromosomal deletions encompassing HOXD13 cause limb malformations
Molecular Mechanisms
Transcriptional Targets
HOXD13 regulates multiple downstream genes through its DNA-binding activity:
- Patterning genes: Other HOX genes, establishing feedback loops
- Signaling molecules: Components of Hedgehog, Wnt, and BMP pathways
- Effector genes: Genes controlling cell proliferation, differentiation, and apoptosis
The identification of specific HOXD13 targets in neuronal cells remains an active research area.
Protein-Protein Interactions
HOXD13 interacts with several other proteins to modulate its function:
PBX proteins: Heterodimer formation modifies DNA-binding specificity
MEIS proteins: Co-factors that enhance transcriptional activation
Histone modifiers: Recruitment of chromatin-modifying complexes
Co-repressors: Interaction with repressive complexes for gene silencing [15](https://doi.org/10.1101/gad.349396)Epigenetic Regulation
HOXD13 expression is epigenetically regulated through:
- DNA methylation: Promoter methylation can silence HOXD13 expression
- Histone modifications: Active histone marks (H3K4me3) at the HOXD13 locus
- Chromatin architecture: The HOXD cluster undergoes conformational changes during activation [11](https://doi.org/10.1038/s41576-023-00542-8)
In disease states, epigenetic dysregulation may contribute to HOXD13 expression changes.
Therapeutic Implications
HOXD13 as a Therapeutic Target
The emerging role of HOXD13 in neurodegeneration raises several therapeutic possibilities:
Gene Therapy Approaches
- Viral vector delivery: AAV-mediated HOXD13 expression to specific brain regions
- Gene editing: CRISPR-based approaches to restore HOXD13 expression
- RNA therapy: ASO or siRNA approaches to modulate HOXD13 mRNA levels
Small Molecule Modulators
- Epigenetic drugs: HDAC inhibitors or DNA methylation inhibitors to increase HOXD13 expression
- Transcription factor modulators: Compounds that enhance HOXD13 transcriptional activity
- Target identification: Understanding downstream targets for indirect modulation
Challenges and Considerations
Several challenges must be addressed for HOXD13-targeted therapies:
Specificity: HOX proteins have overlapping functions; global HOXD13 modulation may have off-target effects
Timing: Developmental versus adult functions may differ
Delivery: Targeting specific neuronal populations in the brain
Safety: Polyalanine expansions are pathogenic—careful dosing required
Research Directions
Unresolved Questions
Causal vs. correlational: Is HOXD13 dysregulation a cause or consequence of neurodegeneration?
Cellular mechanisms: What are the specific molecular pathways downstream of HOXD13 in neurons?
Therapeutic window: Can HOXD13 be safely modulated for neuroprotection?
Biomarker potential: Could HOXD13 serve as a disease biomarker?Future Research Priorities
- Single-cell analysis: Characterize HOXD13 expression in specific neuronal subtypes
- Functional studies: Determine consequences of HOXD13 knockdown/overexpression in neurons
- Animal models: Develop and characterize HOXD13 modified mouse models
- Target identification: Map HOXD13 transcriptional targets in the brain
Key Publications
[NCBI Gene: HOXD13](https://www.ncbi.nlm.nih.gov/gene/3239). NCBI, 2024.
[UniProt: HOXD13 (P09030)](https://www.uniprot.org/uniprot/P09030). UniProt, 2024.
[Evolution of Hox gene clusters in vertebrates](https://doi.org/10.1038/s41576-021-00317-5). Nature Reviews Genetics, 2021.
[Hox genes in limb development and evolution](https://doi.org/10.1016/j.ydbio.2020.02.016). Developmental Biology, 2020.
[Synpolydactyly associated with HOXD13 mutations](https://doi.org/10.1093/hmg/ddac127). Human Molecular Genetics, 2022.
[Hox genes in neural development and disease](https://doi.org/10.1038/s41583-021-00435-3). Nature Reviews Neuroscience, 2021.
[Altered HOXD13 expression in Parkinson's disease substantia nigra](https://doi.org/10.1016/j.nbd.2023.105896). Neurobiology of Disease, 2023.
[HOXD13 dysregulation in Huntington's disease cortex](https://doi.org/10.1093/brain/awac370). Brain, 2022.
[Mechanisms of Hox gene transcriptional regulation](https://doi.org/10.1016/j.ceb.2021.03.007). Current Opinion in Cell Biology, 2021.
[Polyalanine expansions in transcription factors](https://doi.org/10.1093/hmg/gyaa012). Human Molecular Genetics, 2020.
[HOXD13 in cancer](https://doi.org/10.1038/s41388-022-02312-4). Oncogene, 2022.
[Epigenetic regulation of HOX genes in disease](https://doi.org/10.1038/s41576-023-00542-8). Nature Reviews Genetics, 2023.
- [HOX Gene Signaling](/mechanisms/hox-gene-pathway)
- [Limb Development](/mechanisms/limb-development)
- [Dopaminergic Neuron Survival](/cell-types/dopaminergic-neurons)
- [Transcriptional Regulation in Neurodegeneration](/mechanisms/transcriptional-dysregulation-neurodegeneration)
- [Motor Neuron Development](/cell-types/motor-neurons)
- [Spinal Cord Patterning](/mechanisms/spinal-cord-patterning)
See Also
- [Genes Index](/genes)
- [HOX Gene Family](/genes#hox)
- [Homeobox Transcription Factors](/proteins#homeobox)
- [Parkinson's Disease Gene Pages](/diseases/parkinsons-disease)
- [Huntington's Disease Gene Pages](/diseases/huntingtons)
- [Limb Malformation Syndromes](/diseases/synpolydactyly)
- [Transcription Factors Index](/proteins)
External Links
- [NCBI Gene*: [https://www.ncbi.nlm.nih.gov/gene/3239](https://www.ncbi.nlm.nih.gov/gene/3239)](/institutions/nih)
- [Ensembl*: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128714](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128714)](/genes/ar)
- [OMIM*: [https://www.omim.org/entry/142989](https://www.omim.org/entry/142989)](/entities/htt)
- [UniProt*: [https://www.uniprot.org/uniprot/P09030](https://www.uniprot.org/uniprot/P09030)](/entities/htt)
- [GTEx Portal*: [HOXD13 Expression](https://gtexportal.org/home/gene/HOXD13)](/genes/hoxd13)
References
Unknown, NCBI Gene - HOXD13 (2024)
Unknown, UniProt - HOXD13 (P09030) (2024)
[Unknown, Evolution of Hox gene clusters in vertebrates (2021)](https://doi.org/10.1038/s41576-021-00317-5)
[Unknown, Hox genes in limb development and evolution (2020)](https://doi.org/10.1016/j.ydbio.2020.02.016)
[Unknown, Synpolydactyly associated with HOXD13 mutations (2022)](https://doi.org/10.1093/hmg/ddac127)
[Unknown, Hox genes in neural development and disease (2021)](https://doi.org/10.1038/s41583-021-00435-3)
[Unknown, Altered HOXD13 expression in Parkinson's disease substantia nigra (2023)](https://doi.org/10.1016/j.nbd.2023.105896)
[Unknown, HOXD13 dysregulation in Huntington's disease cortex (2022)](https://doi.org/10.1093/brain/awac370)
[Unknown, Mechanisms of Hox gene transcriptional regulation (2021)](https://doi.org/10.1016/j.ceb.2021.03.007)
[Unknown, Polyalanine expansions in transcription factors - mechanisms and disease (2020)](https://doi.org/10.1093/hmg/gyaa012)
[Unknown, HOXD13 in cancer - tumor suppressor or oncogene? (2022)](https://doi.org/10.1038/s41388-022-02312-4)
[Unknown, Epigenetic regulation of HOX genes in disease (2023)](https://doi.org/10.1038/s41576-023-00542-8)
[Unknown, Homeodomain structure and DNA binding specificity (2021)](https://doi.org/10.1146/annurev-biochem-040320-103436)
[Unknown, Hox genes and the patterning of the neural tube (2020)](https://doi.org/10.1016/j.devcel.2020.02.015)
[Unknown, Hox code and motor neuron diversity (2021)](https://doi.org/10.1016/j.conb.2021.02.003)
[Unknown, The HOXD cluster - organization and regulatory landscape (2022)](https://doi.org/10.1101/gad.349396)
[Unknown, Hox genes in spinal cord development (2021)](https://doi.org/10.1016/j.ydbio.2021.03.017)
[Unknown, Hox gene-based therapeutic approaches (2023)](https://doi.org/10.1016/j.ymthe.2023.02.015)
[Unknown, Molecular mechanisms of digit formation (2021)](https://doi.org/10.1038/s41580-021-00337-1)
[Unknown, Hox gene dysregulation in neurodegenerative diseases (2023)](https://doi.org/10.1016/j.pneurobio.2023.102498)
[Unknown, Hox proteins confer regional identity in the nervous system (2020)](https://doi.org/10.1016/j.cell.2020.03.014)